About this CME on Peritoneal Surface Malignancy

HCG Cancer Hospital, Nagpur, in association with the Association of Surgeons, Nagpur, is hosting a CME dedicated to the management of Peritoneal Surface Malignancies. The official invitation describes the program as a focused academic session built around advanced diagnosis, case-based discussions, CRS, and HIPEC-related surgical learning, with the event scheduled for Sunday, 26 April 2026 at Hotel Centre Point, Ramdaspeth, Nagpur. :contentReference[oaicite:2]{index=2}

This event is designed not merely as a formal gathering, but as a meaningful educational platform for clinicians who manage complex oncological cases. With 2 MMC points accredited for the CME, it also offers formal academic value alongside practical knowledge exchange. :contentReference[oaicite:3]{index=3}

Why Peritoneal Surface Malignancy deserves focused academic discussion

Peritoneal Surface Malignancy is one of the more demanding areas in oncology because diagnosis, disease burden assessment, patient selection, surgical planning, and outcomes all depend on careful judgement. These cases often require a multidisciplinary, evidence-based approach rather than a one-size-fits-all pathway.

In real-world clinical practice, the management of peritoneal disease may involve difficult questions around operability, timing of intervention, expected benefit, and the role of advanced treatment approaches such as cytoreductive surgery (CRS) and HIPEC. That is exactly why academic forums like this CME remain important: they create space for surgeons and cancer specialists to review current thinking, practical strategies, and lessons from case experience.

Keynote address by Prof. Lana Bijelic

One of the most important highlights of this session is the keynote by Prof. Lana Bijelic, who is presented in the invitation as an internationally recognized expert in the treatment of peritoneal surface malignancies using cytoreductive surgery (CRS) and intraperitoneal chemotherapy including HIPEC and PIPAC. The invitation further notes her extensive experience, academic leadership, and mentoring role within the European School of Peritoneal Surface Oncology. :contentReference[oaicite:4]{index=4}

For delegates attending in Nagpur, this is a valuable opportunity to hear directly from a global expert whose work has shaped advanced thinking in this field. Academic sessions become especially meaningful when they combine real-world surgical experience with clear teaching on indications, operative judgement, and case selection.

What attendees can expect from the session

The invitation materials and agenda visuals show that the CME is built around a mix of didactic learning, case-led discussion, and focused expert sessions rather than generic lectures alone. The program includes core disease discussions, multidisciplinary moderation, and a keynote segment around surgical video demonstration and key techniques, as well as colorectal peritoneal metastases. :contentReference[oaicite:5]{index=5}

Why clinicians often prefer this format

Educational events become far more useful when they move beyond theory and address the questions doctors actually face in practice: Which patient is suitable? When is surgery appropriate? What changes the treatment plan? What should be avoided? How should borderline cases be approached? A case-based oncology CME helps answer these practical questions in a far more grounded way.

Event details

These published event details are consistent across the invitation pages, including the date, venue, CME credits, and organizing institutions. :contentReference[oaicite:6]{index=6}

Who should attend this CME?

This session should be especially relevant for surgeons, surgical oncologists, gastrointestinal oncology teams, general surgeons with cancer practice, academic trainees, and clinicians who encounter peritoneal disease in referral or hospital settings.

• Consultant surgeons and surgical oncologists
• GI cancer specialists and oncology teams
• General surgeons interested in advanced cancer surgery
• Residents, fellows, and academic trainees
• Clinicians who want better clarity on CRS, HIPEC, and peritoneal disease strategy

Even for clinicians who are not directly performing HIPEC or CRS, the session can still be valuable because better understanding of referral timing, disease patterns, and treatment pathways often improves multidisciplinary care.

Registration and participation

Colleagues interested in attending can register using the official RSVP link shared in the invitation. Early registration is advisable for smooth coordination. If you are planning to attend from Nagpur or nearby regions, this is a strong opportunity to participate in a focused academic discussion on one of the more demanding areas of abdominal oncology.

Frequently Asked Questions